
Apriglim-M 0.5 Tablet PR
Marketer
Aprica Pharmaceuticals Pvt Ltd
Salt Composition
Glimepiride (0.5mg) + Metformin (500mg)
Overview Apriglim-M 0.5 Tablet PR
Diabetol-Duo 0.5mg tablets are classified as antidiabetic agents, combining two medications to manage type 2 diabetes in adults. This medication helps regulate blood glucose levels. Diabetol-Duo 0.5mg should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may adjust based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, risking kidney complications, vision loss, neuropathy, and limb damage. This medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle choices are vital in diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks or juice) are essential preventative measures. Alcohol consumption should be minimized due to its hypoglycemic potential. Additional possible side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals require physician consultation. Regular blood glucose monitoring and periodic blood tests (to check blood cell counts and liver function) are recommended.
Primary Ingredients of Apriglim-M 0.5 Tablet PR
No text provided to rephrase.
Uses of Apriglim-M 0.5 Tablet PR
Managing type 2 diabetes
Major Benefits of Apriglim-M 0.5 Tablet PR:
Follow your doctor's instructions or the product label for proper administration. Consume Apriglim-M 0.5mg Tablet PR with food.
Common Side effects of Apriglim-M 0.5 Tablet PR:
- Headache
- Hypoglycemia (low blood glucose level)
- Nausea
- Diarrhea
How to use Apriglim-M 0.5 Tablet PR:
Follow your physician's instructions or consult the product information leaflet for dosage guidance. Consume Apriglim-M 0.5mg Tablet PR with a meal.
How Apriglim-M 0.5 Tablet PR works:
Apriglim-M 0.5mg tablets combine glimepiride and metformin to manage blood sugar. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release, reducing blood glucose. Metformin, a biguanide, acts threefold: decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Apriglim-M 0.5 mg tablets is not recommended due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The use of Apriglim-M 0.5 Tablet PR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing. Seek medical advice.
Breast feedingUNSAFE
The use of Apriglim-M 0.5 Tablet PR is contraindicated while breastfeeding due to potential infant toxicity. Evidence indicates a risk of harm to the nursing infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should use Apriglim-M 0.5 Tablet PR cautiously, potentially requiring a modified dosage. Consult your physician for guidance. Apriglim-M 0.5 Tablet PR is contraindicated in individuals with severe kidney disease. Routine monitoring of kidney function is recommended during treatment.
LiverCAUTION
Individuals with liver impairment should use Apriglim-M 0.5 Tablet PR cautiously. Dosage modification may be necessary for these patients. Physician consultation is advised. For those with mild to moderate liver disease, Apriglim-M 0.5 Tablet PR is typically initiated at a low dose; however, its use is contraindicated in cases of severe hepatic dysfunction.
What if you forget to take Apriglim-M 0.5 Tablet PR :
Should you forget to take your Apriglim-M 0.5 Tablet PR, administer it immediately. If, however, your next dose is imminent, omit the missed dose and resume your usual dosage regimen. Avoid taking a double dose.
Facts to Know About Apriglim-M 0.5 Tablet PR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
